Clinical trial
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not…
NCT00006095 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006095 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy |
| Official title | A Trial of Irinotecan (NSC# 616348) Plus Vincristine in Children With Solid Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, vincristine sulfate |
| Enrollment | 20 |
| Start date | Jul 1, 2000 |
| Primary completion | Jan 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | May 22, 2003 |
| Last update posted | Feb 21, 2014 |
| Countries | Australia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: